Target Name: LOC107984063
NCBI ID: G107984063
Review Report on LOC107984063 Target / Biomarker Content of Review Report on LOC107984063 Target / Biomarker
LOC107984063
Other Name(s): Uncharacterized LOC107984063, transcript variant X1 | LOC107984063 variant X1

LOC107984063: A Potential Drug Target and Biomarker

LOC107984063 is a gene that has been identified as a potential drug target or biomarker. The gene is located on chromosome 19q and encodes for a protein known as LOC107984063. This protein is a member of the Kallikrein-related peptidases (KrP) family, which are a group of serine proteases that regulate various cellular processes.

The most promising aspect of LOC107984063 is its potential as a drug target. The KrP family has been identified as a potential drug target due to its involvement in various cellular processes, including cell signaling, inflammation, and stress response. Additionally, LOC107984063 has been shown to play a role in the regulation of pain perception and neuroinflammation.

LOC107984063 has also been identified as a potential biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. The protein has been shown to be expressed in various tissues and has been used as a marker for cancer diagnosis and treatment.

The discovery and characterization of LOC107984063 is an important milestone in the study of drug targets and biomarkers. Further research is needed to understand the full potential of this protein and its potential as a drug.

Protein Name: Uncharacterized LOC107984063, Transcript Variant X1

The "LOC107984063 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC107984063 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC107984079 | LOC107984098 | LOC107984108 | LOC107984113 | LOC107984118 | LOC107984129 | LOC107984137 | LOC107984144 | LOC107984145 | LOC107984146 | LOC107984179 | LOC107984214 | LOC107984221 | LOC107984238 | LOC107984251 | LOC107984256 | LOC107984264 | LOC107984284 | LOC107984314 | LOC107984316 | LOC107984326 | LOC107984361 | LOC107984363 | LOC107984381 | LOC107984390 | LOC107984408 | LOC107984526 | LOC107984530 | LOC107984536 | LOC107984543 | LOC107984558 | LOC107984563 | LOC107984567 | LOC107984576 | LOC107984588 | LOC107984625 | LOC107984626 | LOC107984634 | LOC107984647 | LOC107984654 | LOC107984665 | LOC107984671 | LOC107984703 | LOC107984706 | LOC107984710 | LOC107984737 | LOC107984755 | LOC107984782 | LOC107984788 | LOC107984793 | LOC107984798 | LOC107984827 | LOC107984867 | LOC107984869 | LOC107984880 | LOC107984901 | LOC107984903 | LOC107984911 | LOC107984913 | LOC107984928 | LOC107984932 | LOC107984934 | LOC107984942 | LOC107984948 | LOC107984965 | LOC107984993 | LOC107985004 | LOC107985038 | LOC107985067 | LOC107985072 | LOC107985085 | LOC107985096 | LOC107985129 | LOC107985157 | LOC107985165 | LOC107985173 | LOC107985174 | LOC107985179 | LOC107985203 | LOC107985204 | LOC107985211 | LOC107985225 | LOC107985239 | LOC107985250 | LOC107985258 | LOC107985270 | LOC107985323 | LOC107985340 | LOC107985360 | LOC107985393 | LOC107985394 | LOC107985434 | LOC107985440 | LOC107985478 | LOC107985479 | LOC107985511 | LOC107985544 | LOC107985590 | LOC107985593 | LOC107985688